TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT05558839

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: A 12-week weekly sports and cognitive training intervention.
Description: A 12-week weekly sports and cognitive training intervention was provided to the participants. The training, 2 hours each week, involved 1 hour of sports training and 1 hour of cognitive training.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: A 12-week weekly sports and cognitive training intervention.
Description: A 12-week weekly sports and cognitive training intervention was provided to the participants. The training, 2 hours each week, involved 1 hour of sports training and 1 hour of cognitive training.
Study: NCT05694351

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Healthy meals and physical activity in families with type 2 diabetes
Description: Families will participate in telehealth family education on diabetes management and prevention through lifestyle modifications in their everyday occupations regarding current recommendations for physical activity, grocery shopping, meal preparation, and family meal routines. Each family will be assisted in setting tailored goals for the family as a whole and individually regarding physical activity and dieting habits. The goals will be incorporated into family daily routines, to secure manageability and sustainability of the new lifestyle habits. Local facilities and communy networks will be engaged in this process to empower and motivate the participants. Working with the goals will be monitored and facilitated throughout the intervention period of 3 months. Before discharge, each family will co-produce a maintenance plan for physical activity and healthy dieting.
Study: NCT05941598

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Electroacupuncture
Description: Participants in the electroacupuncture group will receive electroacupuncture twice a week, with each session lasting 30 minutes. The treatment will start one week before chemotherapy and continue throughout the chemotherapy period.

Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Sham acupuncture
Description: Participants in the sham acupuncture group will receive minimal acupuncture twice a week, with each session lasting 30 minutes. The treatment will start one week before chemotherapy and continue throughout the chemotherapy period.
Study: NCT05470907

Intervention type: DEVICE
Intervention: Hemoperfusion
Description: Commercial membranes for extracorporeal blood purification (hemoperfusion)
Study: NCT06177756

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Nutritional and lifestyle counseling
Description: At risk children Intervention Arm: schedule at least four visits/year with anthropometric monitoring, educate parents on the appropriate diet, active lifestyle from the first year of life, regular self-monitoring of their child's anthropometry and appropriate dietary composition and portion control, provide tailor-made nutritional suggestions.~Not-at-risk children Intervention Arm: educational website with interactive tools for growth self-monitoring and diverse lifestyle suggestions.
Study: NCT06299527

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Exercise Program
Description: Exercise Program In our study, the telerehabilitation program was applied for both synchronous and asynchronous groups, 3 days a week, 1 session per day, for 8 weeks. The exercises were combined individually according to the person's capacity, and the intensity and duration of the exercise will gradually increase according to the patient's tolerance.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Exercise Program
Description: Exercise Program In our study, the telerehabilitation program was applied for both synchronous and asynchronous groups, 3 days a week, 1 session per day, for 8 weeks. The exercises were combined individually according to the person's capacity, and the intensity and duration of the exercise will gradually increase according to the patient's tolerance.
Study: NCT05134272

Intervention type: DEVICE
Intervention: Neuromuscular electrical stimulation
Description: Neuromuscular Electrical Stimulation will be applied by the therapist to infant's finger flexors and extensor for 15 min./day, 3x/week.

Intervention type: BEHAVIORAL
Intervention: Modified constraint induced movement therapy
Description: Modified CIMT will consist of constraint 24 hours/day using a splint in addition to therapy two hours/day, 3x/week for three weeks. Parents will be trained to carry over home program activities one hour/day, 6 days/week.

Intervention type: BEHAVIORAL
Intervention: Standard care for infant with asymmetrical hand function
Description: Infants will receive one hour of therapy, one time/week for three weeks. Parents will be trained to carry over home program activities one hour/day, 6 days/week. In addition the infant will wear a sock on their preferred hand during the hour of therapy/home program activity.
Study: NCT06100341

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Virtual reality
Description: A role-playing game set in a spaceship in outer space where a user will need to accomplish three activities to complete the game. These activities were designed based on typical therapy goals for children with cerebral palsy of improving balance, gross motor performance, walking speed, and functional mobility.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Virtual reality
Description: A role-playing game set in a spaceship in outer space where a user will need to accomplish three activities to complete the game. These activities were designed based on typical therapy goals for children with cerebral palsy of improving balance, gross motor performance, walking speed, and functional mobility.
Study: NCT05677490

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Magnetic Resonance Imaging
Description: Undergo MRI

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Computed Tomography
Description: Undergo a CT Scan
Study: NCT05665270

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dextenza 0.4Mg Ophthalmic Insert
Description: Group 1 (20 eyes) will receive treatment with topical 1% Prednisolone Acetate drops QID x 1 week, then Dextenza will be inserted at the one-week postoperative evaluation (Day 8). Both groups will receive topical Prolensa Qa.m. x 5 weeks and Moxifloxacin TID x 1 week, per investigators preferential treatment regimen.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Prednisolone Acetate 1%
Description: Group 2 (20 eyes) will receive treatment with topical 1% Prednisolone Acetate for five weeks with dosing schedule: QID x 2 weeks, TID x 1 week, BID x 1 week, QD x 1 week.~Both groups will receive topical Prolensa Qa.m. x 5 weeks and Moxifloxacin TID x 1 week, per investigators preferential treatment regimen.
Study: NCT05087069

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BV100
Description: Rifabutin for Infusion

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Saline intravenous infusion
Study: NCT05677490

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Computed Tomography
Description: Undergo a CT Scan

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Biospecimen Collection
Description: Undergo blood sample collection
Study: NCT05231148

Intervention type: PROCEDURE
Group type: OTHER
Intervention: local debridement and local calcium sulfate loaded by antibiotics
Description: debridement of infected non united fractures and placement of local calcium sulfate loaded by antibiotic then follow up at regular intervals
Study: NCT04842084

Intervention type: BIOLOGICAL
Intervention: Blood samples
Description: sampling of 10 S-Monovette tubes (Sarstedt) 4.3 ml of blood specifically for the study representing a total blood volume of 43 ml
Study: NCT06448403

Intervention type: DEVICE
Intervention: MRI Scanning
Description: MRI scanning with volumetric, resting and activity-based sequences.

Intervention type: DEVICE
Intervention: MRI Scanning
Description: MRI scanning with volumetric, resting and activity-based sequences.

Intervention type: DEVICE
Intervention: MRI Scanning
Description: MRI scanning with volumetric, resting and activity-based sequences.

Intervention type: DEVICE
Intervention: 64-channel EEG
Description: EEG to quantifiy electric activity.

Intervention type: DEVICE
Intervention: 64-channel EEG
Description: EEG to quantifiy electric activity.

Intervention type: DEVICE
Intervention: 64-channel EEG
Description: EEG to quantifiy electric activity.

Intervention type: DEVICE
Intervention: Polysomnography
Description: A randomized group will undergo polysomnography.

Intervention type: DEVICE
Intervention: Polysomnography
Description: A randomized group will undergo polysomnography.

Intervention type: DEVICE
Intervention: Polysomnography
Description: A randomized group will undergo polysomnography.

Intervention type: BIOLOGICAL
Intervention: Blood samples
Description: Analysis of specific blood biomarkers.

Intervention type: BIOLOGICAL
Intervention: Blood samples
Description: Analysis of specific blood biomarkers.

Intervention type: BIOLOGICAL
Intervention: Blood samples
Description: Analysis of specific blood biomarkers.

Intervention type: BIOLOGICAL
Intervention: Fecal samples
Description: Analysis of bacterial composition.

Intervention type: BIOLOGICAL
Intervention: Fecal samples
Description: Analysis of bacterial composition.

Intervention type: BIOLOGICAL
Intervention: Fecal samples
Description: Analysis of bacterial composition.

Intervention type: BEHAVIORAL
Intervention: Cognitive tests
Description: Interview-based cognitive tests for assesment of cognitive levels.

Intervention type: BEHAVIORAL
Intervention: Cognitive tests
Description: Interview-based cognitive tests for assesment of cognitive levels.

Intervention type: BEHAVIORAL
Intervention: Cognitive tests
Description: Interview-based cognitive tests for assesment of cognitive levels.
Study: NCT06182332

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Electronic Health Record Review
Description: Undergo medical record review

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Internet-Based Intervention
Description: Use AI algorithm
Study: NCT05243927

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Aerobic exercise program
Description: Aerobic exercise will be performed under the supervision of a physiotherapist with a treadmill during 40-60 minutes 3 days a week for 8 weeks

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Spinal stabilization exercise program
Description: Spinal stabilization exercises will be performed with a physiotherapist during 40-60 minutes 3 days a week for 8 weeks.
Study: NCT05912465

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Stress Reduction Training
Description: A subgroup of patients from Vienna will undergo an additional PET/CT scan after the first follow-up PET/CT, which takes place one month after stress reduction training. The stress reduction training involves performing a breathing technique.
Study: NCT06203990

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Barre exercise
Description: Group barre exercise class
Study: NCT05011708

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: I-DROP MGD
Description: I-DROP MGD are eye drop produced by I-MED PHARMA for the management of moderate to severe Dry Eye Disease.

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Thealoz Duo
Description: I-DROP MGD are eye drop produced by Laboratoires Thea for the management of Dry Eye Disease.
Study: NCT05043415

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Immediate endoscopic necrosectomy
Description: In the immediate endoscopic necrosectomy group, endoscopic ultrasound-guided drainage of the necrotic collection is performed using a lumen-apposing metal stent, immediately followed by endoscopic necrosectomy. Endoscopic necrosectomy involves removal of infected necrotic pancreatic tissue via the cystogastrostomy/cystoenterostomy tract using a variety of endoscopic accessories.

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Step-up endoscopic interventions
Description: In the step-up endoscopic interventions group, endoscopic ultrasound-guided drainage of the necrotic collection is performed using a lumen-apposing metal stent. Endoscopic necrosectomy is not performed during the index drainage session, but is performed at a later time as needed.
Study: NCT04869085

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: e-PainSupport
Description: Patients and caregivers assigned to the e-PainSupport condition will download the app on their own device, or they will be given a project tablet with wireless capability if they do not have their own device. All receive specific training for the intervention. They will also receive a hardcopy of the e-PainSupport manual and a trouble-shooting guide. Contact information will be provided in the app and on paper for technical problems. Caregivers complete Education Module, and patients may complete it. Caregiver or patient will fill out Pain Report daily. Pain Summary for Nurses is an automatically generated graphic summary of patients' Pain Reports over time. Nurses have access to this information during the time the patients and caregivers use e-PainSupport.
Study: NCT05493943

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Pulsed ElectroMagnetic Field (PEMF) therapy
Description: Application of PEMF using treatment coils in eproximity to the area where treatment is desired.

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Pulsed ElectroMagnetic Field (PEMF) therapy
Description: Application of PEMF using treatment coils in eproximity to the area where treatment is desired.

Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Pulsed ElectroMagnetic (PEMF) therapy
Description: Control arm.
Study: NCT06424782

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: medicinal water
Description: Medicinal water treatment in bath tub once daily.

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: medicinal water
Description: Medicinal water treatment in bath tub once daily.
Study: NCT05093738

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Cognitive Rehabilitation
Description: In the content of the person-centered intervention program, attention, memory, orientation, praxis (motor planning) training; metacognition (metacognition) training; visual perception; There will be cognitive training for executive functions. The intervention will consist of play activities (games, computer-assisted games) for cognitive skills; The games will be applied in a way that suits the child from simple to complex. Visual perception applications (designing blocks, recognizing and sorting the shapes in the picture, matching opposite shapes etc.); attention practices, memory practices, strategy development, space-time orientation, motor planning, games and metacognitive strategies aimed at developing skills such as planning, organization, working memory, impulse control, time management and awareness, abstract thinking, cognitive flexibility will form our intervention program.
Study: NCT05405179

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Simultaneous dental implantation
Description: To perform dental implantation simultaneously in free vascularized bone flaps for jaw reconstruction using patient-specific surgical guides and titanium plates
Study: NCT05677490

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Biospecimen Collection
Description: Undergo blood sample collection
Study: NCT06301880

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: The topical application of a vasodilator on the LIMA graft
Description: Patients were randomly assigned to receive the topical application of one of three agents: milrinone (Baxter Pharmaceuticals, Ahmedabad, India) 10 mg in 20 ml of dextrose 5%, nitroglycerin (Caspian Tamin Pharmaceutical, Guilan, Iran) 10 mg in 20 ml of normal saline, or normal saline (0.9% sodium chloride solution) as control.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: The topical application of a vasodilator on the LIMA graft
Description: Patients were randomly assigned to receive the topical application of one of three agents: milrinone (Baxter Pharmaceuticals, Ahmedabad, India) 10 mg in 20 ml of dextrose 5%, nitroglycerin (Caspian Tamin Pharmaceutical, Guilan, Iran) 10 mg in 20 ml of normal saline, or normal saline (0.9% sodium chloride solution) as control.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: The topical application of a vasodilator on the LIMA graft
Description: Patients were randomly assigned to receive the topical application of one of three agents: milrinone (Baxter Pharmaceuticals, Ahmedabad, India) 10 mg in 20 ml of dextrose 5%, nitroglycerin (Caspian Tamin Pharmaceutical, Guilan, Iran) 10 mg in 20 ml of normal saline, or normal saline (0.9% sodium chloride solution) as control.
Study: NCT05511168

Intervention type: PROCEDURE
Group type: OTHER
Intervention: Craniostnostosis surgery
Description: Surgery of craniosynostosis
Study: NCT06297668

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Treatment A: BGF MDI HFA
Description: Participants will receive 4 inhalations of BGF MDI HFA as a single dose with AeroChamber Plus Flow-Vu spacer.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Treatment B: BGF MDI HFO
Description: Participants will receive 4 inhalations of BGF MDI HFO as a single dose with AeroChamber Plus Flow-Vu spacer.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Treatment C: BGF MDI HFO
Description: Participants will receive 4 inhalations of BGF MDI HFO as a single dose without spacer.

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: AeroChamber Plus Flow-Vu spacer
Description: Participants will receive 4 inhalations of BGF MDI HFA (Treatment A) and BGF MDI HFO (Treatment B) as a single dose with spacer.

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: AeroChamber Plus Flow-Vu spacer
Description: Participants will receive 4 inhalations of BGF MDI HFA (Treatment A) and BGF MDI HFO (Treatment B) as a single dose with spacer.
Study: NCT06185673

Intervention type: GENETIC
Group type: EXPERIMENTAL
Intervention: BB-301: Dose escalation phase 1b cohort 1
Description: BB-301 is composed of an AAV9 capsid, AAV9PL, which delivers the gene of interest, comprised of a recombinant genome encoding a single RNA transcript that produces a codon-optimized, wildtype PABPN1 protein as well as 2 short hairpin (sh)RNAs directed against the disease-causing mutant PABPN1 gene.~Subjects in cohort 1 in the dose escalation phase of the study will receive a fixed number of intramuscular (IM) injections of BB-301 into the respective pharyngeal constrictor muscles on the day of dosing, with a total dose of 1.2e13 vg/subject.

Intervention type: GENETIC
Group type: EXPERIMENTAL
Intervention: BB-301: Dose escalation phase 1b cohort 2
Description: BB-301 is composed of an AAV9 capsid, AAV9PL, which delivers the gene of interest, comprised of a recombinant genome encoding a single RNA transcript that produces a codon-optimized, wildtype PABPN1 protein as well as 2 shRNAs directed against the disease-causing mutant PABPN1 gene.~Subjects in cohort 2 in the dose escalation phase of the study will receive a fixed number of IM injections of BB-301 into the respective pharyngeal constrictor muscles on the day of dosing, with a total dose of 3.6e13 vg/subject.

Intervention type: GENETIC
Group type: EXPERIMENTAL
Intervention: BB-301: Dose escalation phase 1b cohort 3
Description: BB-301 is composed of an AAV9 capsid, AAV9PL, which delivers the gene of interest, comprised of a recombinant genome encoding a single RNA transcript that produces a codon-optimized, wildtype PABPN1 protein as well as 2 shRNAs directed against the disease-causing mutant PABPN1 gene.~Subjects in cohort 3 in the dose escalation phase of the study will receive a fixed number of IM injections of BB-301 into the respective pharyngeal constrictor muscles on the day of dosing, with a total dose of 5.4e13 vg/subject.

Intervention type: GENETIC
Group type: EXPERIMENTAL
Intervention: BB-301: Dose expansion phase 2a
Description: Subjects in the dose expansion phase of the study will receive a fixed number of IM injections of BB-301 into the respective pharyngeal constrictor muscles on the day of dosing, at the maximum tolerated dose (MTD)/recommended phase 2 dose (RP2D).
Study: NCT05990673

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Remimazolam
Description: remimazolam is given intravenously
Study: NCT05969509

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: progressive relaxation exercise
Description: applying progressive relaxation exercise to the experimental group after postoperative cholecystectomy and observing the experimental-control groups
Study: NCT06253156

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: virtual reality
Description: It is planned to provide 4 sessions of standard disaster preparedness training to nursing students in the intervention group. After the standard training sessions are completed, nursing students will be shown disaster simulation videos and visuals using virtual reality glasses within the scope of the virtual reality-based disaster preparedness training program.
Study: NCT06409312

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Akina Cloud
Description: Akina Cloud is a digital health application that supports the therapeutic training of people with musculoskeletal conditions. It provides two therapeutic training programs for patients, one for each specific indication. Patients have continuous access to these programs through Akina Cloud, allowing them to independently complete nine training sessions without supervision. A minimum of three sessions per week is recommended, but patients have the option to engage in daily sessions if preferred. These therapy programs are based on current treatment guidelines and supported by relevant scientific research. They include customizable physical exercises tailored to individual needs and difficulty levels. Patients receive audio-visual guidance during these exercise sessions to ensure proper execution. Exercise therapy has demonstrated its ability to reduce pain, improve physical function, and enhance the overall quality of life for patients suffering from back pain and hip osteoarthritis.
Study: NCT05741255

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Acceptance and Commitment Therapy
Description: type of mindful psychotherapy that helps you stay focused on the present moment and accept thoughts and feelings without judgment. It aims to help you move forward through difficult emotions so you can put your energy into healing instead of dwelling on the negative.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Acceptance and Commitment Therapy
Description: type of mindful psychotherapy that helps you stay focused on the present moment and accept thoughts and feelings without judgment. It aims to help you move forward through difficult emotions so you can put your energy into healing instead of dwelling on the negative.
Study: NCT05677490

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Questionnaire Administration
Description: Ancillary studies

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Questionnaire Administration
Description: Ancillary studies